Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: A case-control study
Aim The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA). Material and Methods We conducted a case–control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 pati...
Saved in:
| Published in | The journal of obstetrics and gynaecology research Vol. 39; no. 5; pp. 1019 - 1023 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Australia
Blackwell Publishing Ltd
01.05.2013
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1341-8076 1447-0756 1447-0756 |
| DOI | 10.1111/jog.12018 |
Cover
| Abstract | Aim
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA).
Material and Methods
We conducted a case–control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals.
Results
As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm3), higher C‐reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3–527, P < 0.0001).
Conclusion
An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated. |
|---|---|
| AbstractList | Aim
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA).
Material and Methods
We conducted a case–control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals.
Results
As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm3), higher C‐reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3–527, P < 0.0001).
Conclusion
An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated. The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA).AIMThe aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA).We conducted a case-control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals.MATERIAL AND METHODSWe conducted a case-control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals.As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm³), higher C-reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3-527, P < 0.0001).RESULTSAs per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm³), higher C-reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3-527, P < 0.0001).An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated.CONCLUSIONAn abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated. The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA). We conducted a case-control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals. As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm³), higher C-reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3-527, P < 0.0001). An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated. |
| Author | Ishikawa, Masahiko Hirahara, Fumiki Yoshida, Hiroshi Mizushima, Taichi Ohi, Yuka |
| Author_xml | – sequence: 1 givenname: Taichi surname: Mizushima fullname: Mizushima, Taichi email: mizusima@yokohama-cu.ac.jp organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan – sequence: 2 givenname: Hiroshi surname: Yoshida fullname: Yoshida, Hiroshi organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan – sequence: 3 givenname: Yuka surname: Ohi fullname: Ohi, Yuka organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan – sequence: 4 givenname: Masahiko surname: Ishikawa fullname: Ishikawa, Masahiko organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan – sequence: 5 givenname: Fumiki surname: Hirahara fullname: Hirahara, Fumiki organization: Department of Obstetrics and Gynecology, Yokohama City University School of Medicine, Kanagawa, Yokohama, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23509912$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1u1DAUhS1URH9gwQsgL2GRNo7t2MOuGspAVVEJ8bO0bpyb4jYTB9sZmD59PZ0ZFgi8sSV_35V9zjE5GPyAhLxk5SnL6-zW35yyqmT6CTliQqiiVLI-yGcuWKFLVR-S4xhvy5KpGdPPyGHFZTmbseqI3F-soJ8gueGGph9Ig4t3tAObfIi084G2uMLej5v7gNHFBINFmjwdIeCQMEC_EQOM60c-TY0v_AqCg4FCEy3G-JaeUwsRC-uHFHxPY5ra9XPytIM-4ovdfkK-vr_4Mv9QXF0vPs7PrworJNdFVWuJ2rYKVds2bccVdCgFyq5RVnDJBDChG9FwYBqZrJkSGivLrGBgueAn5PV27hj8zwljMkuXn9X3MKCfoskp1VJXSrKMvtqhU7PE1ozBLSGszT6vDJxtARt8jAE7Y13K6W3-Ba43rDSbRkxuxDw2ko03fxn7of9id9N_uR7X_wfN5fVibxRbIxeDv_8YEO5MrbiS5vunhZl9frf4dimUmfMH46yrSw |
| CitedBy_id | crossref_primary_10_5180_jsgoe_31_166 crossref_primary_10_1016_j_jogoh_2020_101983 crossref_primary_10_1080_01443615_2017_1405927 crossref_primary_10_5180_jsgoe_39_2_34 crossref_primary_10_1186_s40792_015_0069_6 crossref_primary_10_3109_01443615_2014_991294 crossref_primary_10_1016_j_ijgo_2016_04_006 crossref_primary_10_1016_j_idcr_2025_e02184 crossref_primary_10_1159_000381772 crossref_primary_10_1016_j_ejogrb_2021_01_011 crossref_primary_10_1111_jog_15870 crossref_primary_10_1016_j_ejogrb_2019_05_004 crossref_primary_10_3892_etm_2019_7699 |
| Cites_doi | 10.1097/00003081-196903000-00015 10.1016/0002-9378(56)90174-0 10.1002/(SICI)1098-0997(2000)8:2<88::AID-IDOG5>3.0.CO;2-X 10.1016/S0015-0282(16)58088-1 10.1093/clinids/5.5.876 10.1111/j.0001-6349.2005.00509.x 10.1016/0002-9378(85)90392-8 10.1016/0002-9378(64)90604-0 10.1016/j.ejogrb.2003.10.032 10.2214/ajr.158.3.1738998 10.1097/00003081-199306000-00022 10.1016/S0001-2998(88)80041-2 10.1016/j.ajog.2005.06.019 10.1046/j.1469-0705.1998.12010056.x 10.1097/OGX.0b013e3181b8b0d6 10.1016/j.fertnstert.2004.01.032 10.1016/S0002-9378(98)70333-3 10.1016/0002-9378(80)91107-2 10.1111/j.1447-0756.1997.tb00867.x |
| ContentType | Journal Article |
| Copyright | 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology. |
| Copyright_xml | – notice: 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology – notice: 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology. |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/jog.12018 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1447-0756 |
| EndPage | 1023 |
| ExternalDocumentID | 23509912 10_1111_jog_12018 JOG12018 ark_67375_WNG_9RDGVJ47_C |
| Genre | article Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ZZTAW ~IA ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ALVPJ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c4538-2685e8cd7e7ddbdf37afe54e5fb7c43514a148b4b3a18e1561748e2c1c41ac343 |
| IEDL.DBID | DR2 |
| ISSN | 1341-8076 1447-0756 |
| IngestDate | Fri Jul 11 01:41:01 EDT 2025 Mon Jul 21 05:14:15 EDT 2025 Tue Jul 01 02:30:35 EDT 2025 Thu Apr 24 22:57:17 EDT 2025 Tue Sep 09 05:12:22 EDT 2025 Wed Oct 30 09:49:28 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4538-2685e8cd7e7ddbdf37afe54e5fb7c43514a148b4b3a18e1561748e2c1c41ac343 |
| Notes | istex:8240D928E3DC051A1CA57C35B0A94FE17432D0EC ArticleID:JOG12018 ark:/67375/WNG-9RDGVJ47-C ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 23509912 |
| PQID | 1346582751 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_1346582751 pubmed_primary_23509912 crossref_citationtrail_10_1111_jog_12018 crossref_primary_10_1111_jog_12018 wiley_primary_10_1111_jog_12018_JOG12018 istex_primary_ark_67375_WNG_9RDGVJ47_C |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2013 |
| PublicationDateYYYYMMDD | 2013-05-01 |
| PublicationDate_xml | – month: 05 year: 2013 text: May 2013 |
| PublicationDecade | 2010 |
| PublicationPlace | Australia |
| PublicationPlace_xml | – name: Australia |
| PublicationTitle | The journal of obstetrics and gynaecology research |
| PublicationTitleAlternate | J Obstet Gynaecol Res |
| PublicationYear | 2013 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 1998; 12: 56-66. Chen MJ, Yang JH, Yang YS, Ho HN. Increased occurrence of tubo-ovarian abscesses in women with stage III and IV endometriosis. Fertil Steril 2004; 82: 498-499. Sørbye IK, Jerve F, Staff AC. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade. Acta Obstet Gynecol Scand 2005; 84: 290-296. Cerha HT, Collins CG, Nix FJ. Ruptured tuboovarian abscess. Am J Obstet Gynecol 1956; 72: 820-829. Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: A retrospective review. Am J Obstet Gynecol 1980; 138: 1055-1058. Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: A study of 302 cases. Am J Obstet Gynecol 2005; 193: 1323-1330. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993; 36: 433-444. McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998; 178: 1272-1278. Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Melis GB. Transvaginal ultrasonography combined with CA-125 plasma levels in the diagnosis of endometrioma. Fertil Steril 1996; 65: 293-298. Landers DV, Sweet RL. Tubo-ovarian abscess: Contemporary approach to management. Rev Infect Dis 1983; 5: 876-884. Protopapas AG, Diakomanolis ES, Milingos SD et al. Tubo-ovarian abscesses in postmenopausal women: Gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004; 114: 203-209. Jamieson DJ, Duerr A, Macasaet MA, Peterson HB, Hillis SD. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2000; 8: 88-93. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47 (RR-1): 1-111. Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61: 113-114. Pedowitz P, Bloomfield RD. Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 1964; 88: 721-729. Wilbur AC, Aizenstein RI, Napp TE. CT findings in tuboovarian abscess. AJR Am J Roentgenol 1992; 158: 575-579. Mickal A, Sellmann AH. Management of tubo-ovarian abscess. Clin Obstet Gynecol 1969; 12: 252-264. Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009; 64: 681-689. Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151: 1098-1110. Kubota T, Ishi K, Takeuchi H. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. J Obstet Gynaecol Res 1997; 23: 421-426. Gagliardi PD, Hoffer PB, Rosenfield AT. Correlative imaging in abdominal infection: An algorithmic approach using nuclear medicine, ultrasound, and computed tomography. Semin Nucl Med 1988; 18: 320-334. 1993; 36 1980; 138 2005; 193 2004; 114 2004; 82 2009; 64 1956; 72 1988; 18 2000; 8 1992; 158 1983; 5 1997; 23 1969; 12 2005; 84 1964; 88 1983; 61 1998; 178 1985; 151 1998; 12 1996; 65 1998; 47 (e_1_2_6_6_1) 1998; 47 e_1_2_6_21_1 e_1_2_6_20_1 Hager WD (e_1_2_6_10_1) 1983; 61 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_19_1 e_1_2_6_5_1 Cerha HT (e_1_2_6_3_1) 1956; 72 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_22_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 |
| References_xml | – reference: Chen MJ, Yang JH, Yang YS, Ho HN. Increased occurrence of tubo-ovarian abscesses in women with stage III and IV endometriosis. Fertil Steril 2004; 82: 498-499. – reference: Mickal A, Sellmann AH. Management of tubo-ovarian abscess. Clin Obstet Gynecol 1969; 12: 252-264. – reference: Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47 (RR-1): 1-111. – reference: Sørbye IK, Jerve F, Staff AC. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade. Acta Obstet Gynecol Scand 2005; 84: 290-296. – reference: Wilbur AC, Aizenstein RI, Napp TE. CT findings in tuboovarian abscess. AJR Am J Roentgenol 1992; 158: 575-579. – reference: Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: A study of 302 cases. Am J Obstet Gynecol 2005; 193: 1323-1330. – reference: Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: A retrospective review. Am J Obstet Gynecol 1980; 138: 1055-1058. – reference: Jamieson DJ, Duerr A, Macasaet MA, Peterson HB, Hillis SD. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2000; 8: 88-93. – reference: Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Melis GB. Transvaginal ultrasonography combined with CA-125 plasma levels in the diagnosis of endometrioma. Fertil Steril 1996; 65: 293-298. – reference: Gagliardi PD, Hoffer PB, Rosenfield AT. Correlative imaging in abdominal infection: An algorithmic approach using nuclear medicine, ultrasound, and computed tomography. Semin Nucl Med 1988; 18: 320-334. – reference: Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 1998; 12: 56-66. – reference: Pedowitz P, Bloomfield RD. Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 1964; 88: 721-729. – reference: Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009; 64: 681-689. – reference: Landers DV, Sweet RL. Tubo-ovarian abscess: Contemporary approach to management. Rev Infect Dis 1983; 5: 876-884. – reference: Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151: 1098-1110. – reference: Protopapas AG, Diakomanolis ES, Milingos SD et al. Tubo-ovarian abscesses in postmenopausal women: Gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004; 114: 203-209. – reference: Cerha HT, Collins CG, Nix FJ. Ruptured tuboovarian abscess. Am J Obstet Gynecol 1956; 72: 820-829. – reference: McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998; 178: 1272-1278. – reference: Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61: 113-114. – reference: Kubota T, Ishi K, Takeuchi H. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. J Obstet Gynaecol Res 1997; 23: 421-426. – reference: Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993; 36: 433-444. – volume: 8 start-page: 88 year: 2000 end-page: 93 article-title: Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease publication-title: Infect Dis Obstet Gynecol – volume: 5 start-page: 876 year: 1983 end-page: 884 article-title: Tubo‐ovarian abscess: Contemporary approach to management publication-title: Rev Infect Dis – volume: 12 start-page: 56 year: 1998 end-page: 66 article-title: Transvaginal sonographic markers of tubal inflammatory disease publication-title: Ultrasound Obstet Gynecol – volume: 88 start-page: 721 year: 1964 end-page: 729 article-title: Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis publication-title: Am J Obstet Gynecol – volume: 23 start-page: 421 year: 1997 end-page: 426 article-title: A study of tubo‐ovarian and ovarian abscesses, with a focus on cases with endometrioma publication-title: J Obstet Gynaecol Res – volume: 36 start-page: 433 year: 1993 end-page: 444 article-title: Progress in the management of tuboovarian abscesses publication-title: Clin Obstet Gynecol – volume: 84 start-page: 290 year: 2005 end-page: 296 article-title: Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade publication-title: Acta Obstet Gynecol Scand – volume: 64 start-page: 681 year: 2009 end-page: 689 article-title: Tubo‐ovarian abscess management options for women who desire fertility publication-title: Obstet Gynecol Surv – volume: 82 start-page: 498 year: 2004 end-page: 499 article-title: Increased occurrence of tubo‐ovarian abscesses in women with stage III and IV endometriosis publication-title: Fertil Steril – volume: 158 start-page: 575 year: 1992 end-page: 579 article-title: CT findings in tuboovarian abscess publication-title: AJR Am J Roentgenol – volume: 178 start-page: 1272 year: 1998 end-page: 1278 article-title: Medically sound, cost‐effective treatment for pelvic inflammatory disease and tuboovarian abscess publication-title: Am J Obstet Gynecol – volume: 72 start-page: 820 year: 1956 end-page: 829 article-title: Ruptured tuboovarian abscess publication-title: Am J Obstet Gynecol – volume: 193 start-page: 1323 year: 2005 end-page: 1330 article-title: Transvaginal ultrasound‐guided aspiration for treatment of tubo‐ovarian abscess: A study of 302 cases publication-title: Am J Obstet Gynecol – volume: 138 start-page: 1055 year: 1980 end-page: 1058 article-title: Tubo‐ovarian abscess: A retrospective review publication-title: Am J Obstet Gynecol – volume: 12 start-page: 252 year: 1969 end-page: 264 article-title: Management of tubo‐ovarian abscess publication-title: Clin Obstet Gynecol – volume: 114 start-page: 203 year: 2004 end-page: 209 article-title: Tubo‐ovarian abscesses in postmenopausal women: Gynecological malignancy until proven otherwise? publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 61 start-page: 113 year: 1983 end-page: 114 article-title: Criteria for diagnosis and grading of salpingitis publication-title: Obstet Gynecol – volume: 151 start-page: 1098 year: 1985 end-page: 1110 article-title: Current trends in the diagnosis and treatment of tuboovarian abscess publication-title: Am J Obstet Gynecol – volume: 47 start-page: 1 issue: RR‐1 year: 1998 end-page: 111 article-title: 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention publication-title: MMWR Recomm Rep – volume: 18 start-page: 320 year: 1988 end-page: 334 article-title: Correlative imaging in abdominal infection: An algorithmic approach using nuclear medicine, ultrasound, and computed tomography publication-title: Semin Nucl Med – volume: 65 start-page: 293 year: 1996 end-page: 298 article-title: Transvaginal ultrasonography combined with CA‐125 plasma levels in the diagnosis of endometrioma publication-title: Fertil Steril – ident: e_1_2_6_5_1 doi: 10.1097/00003081-196903000-00015 – volume: 72 start-page: 820 year: 1956 ident: e_1_2_6_3_1 article-title: Ruptured tuboovarian abscess publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(56)90174-0 – ident: e_1_2_6_9_1 doi: 10.1002/(SICI)1098-0997(2000)8:2<88::AID-IDOG5>3.0.CO;2-X – ident: e_1_2_6_14_1 doi: 10.1016/S0015-0282(16)58088-1 – ident: e_1_2_6_18_1 doi: 10.1093/clinids/5.5.876 – volume: 47 start-page: 1 issue: 1 year: 1998 ident: e_1_2_6_6_1 article-title: 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention publication-title: MMWR Recomm Rep – volume: 61 start-page: 113 year: 1983 ident: e_1_2_6_10_1 article-title: Criteria for diagnosis and grading of salpingitis publication-title: Obstet Gynecol – ident: e_1_2_6_15_1 doi: 10.1111/j.0001-6349.2005.00509.x – ident: e_1_2_6_8_1 doi: 10.1016/0002-9378(85)90392-8 – ident: e_1_2_6_4_1 doi: 10.1016/0002-9378(64)90604-0 – ident: e_1_2_6_21_1 doi: 10.1016/j.ejogrb.2003.10.032 – ident: e_1_2_6_13_1 doi: 10.2214/ajr.158.3.1738998 – ident: e_1_2_6_2_1 doi: 10.1097/00003081-199306000-00022 – ident: e_1_2_6_12_1 doi: 10.1016/S0001-2998(88)80041-2 – ident: e_1_2_6_17_1 doi: 10.1016/j.ajog.2005.06.019 – ident: e_1_2_6_11_1 doi: 10.1046/j.1469-0705.1998.12010056.x – ident: e_1_2_6_22_1 doi: 10.1097/OGX.0b013e3181b8b0d6 – ident: e_1_2_6_20_1 doi: 10.1016/j.fertnstert.2004.01.032 – ident: e_1_2_6_7_1 doi: 10.1016/S0002-9378(98)70333-3 – ident: e_1_2_6_16_1 doi: 10.1016/0002-9378(80)91107-2 – ident: e_1_2_6_19_1 doi: 10.1111/j.1447-0756.1997.tb00867.x |
| SSID | ssj0017918 |
| Score | 2.0361767 |
| Snippet | Aim
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA).
Material... The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA). We conducted... The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA).AIMThe aim of... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1019 |
| SubjectTerms | Abscess - microbiology Abscess - physiopathology Abscess - surgery Abscess - therapy Adult Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use antibiotic therapy Case-Control Studies Chlamydia Infections - drug therapy Chlamydia Infections - epidemiology Chlamydia trachomatis - drug effects Chlamydia trachomatis - isolation & purification Drug Resistance, Bacterial - drug effects Fallopian Tube Diseases - microbiology Fallopian Tube Diseases - physiopathology Fallopian Tube Diseases - surgery Fallopian Tube Diseases - therapy Female Humans Infusions, Parenteral Japan - epidemiology Middle Aged Ovarian Diseases - microbiology Ovarian Diseases - physiopathology Ovarian Diseases - surgery Ovarian Diseases - therapy pelvic inflammatory disease Risk Factors Severity of Illness Index surgery tubo-ovarian abscess |
| Title | Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: A case-control study |
| URI | https://api.istex.fr/ark:/67375/WNG-9RDGVJ47-C/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.12018 https://www.ncbi.nlm.nih.gov/pubmed/23509912 https://www.proquest.com/docview/1346582751 |
| Volume | 39 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCiWX9JXHpg_UUkIuXrAlWd72FPLYsJAUQtLmEBCSrN1Dgl2y3tD2UPYnFPoP80s6Iz_alBRCL8aHsZGlmdE31sw3AG-Fty7n0kdSWR4JvEaGO3SGRA2SZGmWOSoUPjxKD07F6EyeLcD7tham5ofofriRZQR_TQZu7PRPIy8n_Ri3Lyr0jXlKvPm7xx11FLFuhjI49NJEuJs2rEIhi6d98tZe9ICm9ctdQPM2bg0bz_4jOG-HXOebXPRnle27b3-xOf7nNz2G5QaQsu1ag57Agi-ewsPD5sj9GXzfa_jAiwlDsMgoF501XXoYIl72u-yKYehOcBT1iFUlo9x2WjZ8e13l9TXIVzNb3sx_lNcYpZuC4dCoUuEd22YOd9Sb-c8me54F5tsVON3fO9k5iJqmDZET5DyTNJM-c7nyKs9tPubKjL0UXo6tcoLqBgxGYFZYbuLMY_SIIVHmExc7ERvHBV-FxaIs_Dqwsc25Ut6lXkmhVD7ghvqCxAOMClKfpT3YapdPu4bRnBprXOousiknOsxnD950op9rGo-7hDaDDnQS5uqC8t6U1J-OhnpwvDv8OBJK7_TgdaskGq2RjlhM4cvZVKO6IaRLlIx7sFZrT_e2hCM4G8QJDjvowL8HokcfhuFm4_6iz2EpCZ06KBfzBSxWVzP_EvFSZV8Fw_gFCScTDw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVgIuvB_L0yCEuGSlxE7sRVyqPnZZuotUtbAXZNmOdw9FCSpZBBxQfwIS_7C_hBnnQVsVCXGJcphEjjMz_sae-QbgmfDW5Tz1USotjwReI8MdOkOiBklUppSjQuHJNBvti_Esna3Aq7YWpuaH6DbcyDKCvyYDpw3pk1ZeLvoxrl_qAqwJBBoUem3uduRRxLsZCuHQTxPlbtbwCoU8nvbRU6vRGk3s1_Og5mnkGpae7avwoR10nXFy0F9Wtu--n-Fz_N-vugZXGkzK1mslug4rvrgBFyfNqftN-LHVUIIXC4Z4kVE6Omsa9TAEvexP5RXD6J0QKaoSq0pG6e305_DtdaHXtyBfLW15fPSz_IKBuimYQd-FDvclW2cOF9Xjo19NAj0L5Le3YH97a29jFDV9GyInyH8mmUq9crn0Ms9tPufSzH0qfDq30gkqHTAYhFlhuYmVxwASoyLlExc7ERvHBb8Nq0VZ-LvA5jbnUnqXeZkKKfMBN9QaJB5gYJB5lfXgRfv_tGtIzam3xkfdBTflQof57MHTTvRTzeRxntDzoASdhDk8oNQ3mer306Ee7G4O342F1Bs9eNJqiUaDpFMWU_hy-VmjviGqS2Qa9-BOrT7d2xKO-GwQJzjsoAR_H4gevx2Gm3v_LvoYLo32Jjt65_X0zX24nITGHZSa-QBWq8Olf4jwqbKPgpX8BimKFy4 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq48H5seRmEEJeslNiOs3Cq2u6WhS6ootADkmU7zh5aJVXJIuCA-hOQ-If9Jcw4DygqEuIS5TCJHHtm_E088w3AY-Gty7n0kVSWRwKvkeEOnSFRgyRZmmWOCoV3Zun2npjuy_0leN7VwjT8EP0PN7KM4K_JwI_y4ncjr-bDGLev7AKsiBSRBCGi3Z47img3Qx0cumli3E1bWqGQxtM9emYzWqF5_Xwe0jwLXMPOM74MH7oxNwknB8NFbYfu6x90jv_5UVfgUotI2XqjQldhyZfXYHWnPXO_Dt-2WkLwcs4QLTJKRmdtmx6GkJf9qrtiGLsTHkVFYnXFKLmd1g3f3pR5fQny9cJWpyffq08YppuSGfRc6G6fsXXmcEs9PfnRps-zQH17A_bGW283tqO2a0PkBHnPJM2kz1yuvMpzmxdcmcJL4WVhlRNUOGAwBLPCchNnHsNHjIkyn7jYidg4LvhNWC6r0t8GVticK-Vd6pUUSuUjbqgxSDzCsCD1WTqAp93yaddSmlNnjUPdhzbVXIf5HMCjXvSo4fE4T-hJ0IFewhwfUOKbkvr9bKJHu5uTd1Oh9MYAHnZKotEc6YzFlL5afNSobojpEiXjAdxqtKd_W8IRnY3iBIcddODvA9HT15Nws_bvog9g9c3mWL96MXt5By4moWsH5WXeheX6eOHvIXaq7f1gIz8B3cIV3Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+the+risk+factors+for+developing+resistance+to+parenteral+therapy+for+tubo-ovarian+abscess%3A+A+case-control+study&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Mizushima%2C+Taichi&rft.au=Yoshida%2C+Hiroshi&rft.au=Ohi%2C+Yuka&rft.au=Ishikawa%2C+Masahiko&rft.date=2013-05-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1341-8076&rft.eissn=1447-0756&rft.volume=39&rft.issue=5&rft.spage=1019&rft.epage=1023&rft_id=info:doi/10.1111%2Fjog.12018&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_9RDGVJ47_C |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon |